---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-024083"
form_type: "8-K"
ticker: "MIST"
cik: "0001408443"
company_name: "Milestone Pharmaceuticals Inc."
filed_at: "2022-02-16T23:59:59+00:00"
generated_at: "2026-06-27T07:27:06.436400+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Milestone Pharmaceuticals appoints Dr. David Bharucha as CMO; grants 330,000 option inducement award

## Summary
- Appointed Dr. David Bharucha as CMO effective Feb 15, 2022.
- Granted inducement option to purchase 330,000 common shares vesting over 4 years.
- Base salary $445,000 and target annual bonus of 40% of base salary.
- Prior CMO Francis Plat becomes Chief Scientific Officer; advisory role after RAPID trial.

## SEC filing metadata
- accession: 0001104659-22-024083
- form_type: 8-K
- ticker: MIST
- cik: 0001408443
- company_name: Milestone Pharmaceuticals Inc.
- filed_at: 2022-02-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1408443/000110465922024083/0001104659-22-024083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1408443/000110465922024083/tm226897d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-024083
- JSON: https://secwatch.observer/filing/0001104659-22-024083.json
- Plain text: https://secwatch.observer/filing/0001104659-22-024083.txt

## Key facts
- Executive change
  David Bharucha was appointed as Chief Medical Officer at Milestone Pharmaceuticals Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: Appointment of Chief Medical Officer On February 16, 2022, the Company announced the appointment of Dr. Bharucha as the Company’s Chief Medical Officer, effective February 15, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1408443/000110465922024083/0001104659-22-024083-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.